位置:首页 > 蛋白库 > BMRA_BACSU
BMRA_BACSU
ID   BMRA_BACSU              Reviewed;         589 AA.
AC   O06967; Q795F6;
DT   26-MAY-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   03-AUG-2022, entry version 153.
DE   RecName: Full=Multidrug resistance ABC transporter ATP-binding/permease protein BmrA;
DE            EC=7.6.2.-;
GN   Name=bmrA; Synonyms=yvcC; OrderedLocusNames=BSU34820;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168;
RA   Denizot F.;
RL   Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V.,
RA   Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R.,
RA   Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S.,
RA   Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K.,
RA   Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F.,
RA   Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D.,
RA   Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M.,
RA   Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P.,
RA   Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K.,
RA   Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S.,
RA   Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y.,
RA   Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G.,
RA   Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M.,
RA   Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y.,
RA   Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J.,
RA   Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A.,
RA   Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M.,
RA   Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S.,
RA   Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E.,
RA   Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [3]
RP   BIOPHYSICOCHEMICAL PROPERTIES, HOECHST 33342 AS SUBSTRATE, AND INHIBITION
RP   BY VANADATE.
RX   PubMed=12225846; DOI=10.1016/s0005-2736(02)00515-1;
RA   Steinfels E., Orelle C., Dalmas O., Penin F., Miroux B., Di Pietro A.,
RA   Jault J.-M.;
RT   "Highly efficient over-production in E. coli of YvcC, a multidrug-like ATP-
RT   binding cassette transporter from Bacillus subtilis.";
RL   Biochim. Biophys. Acta 1565:1-5(2002).
RN   [4]
RP   SUBUNIT, RING FORMATION, AND STRUCTURE BY ELECTRON MICROSCOPY.
RX   PubMed=11827477; DOI=10.1006/jmbi.2001.5309;
RA   Chami M., Steinfels E., Orelle C., Jault J.-M., Di Pietro A., Rigaud J.-L.,
RA   Marco S.;
RT   "Three-dimensional structure by cryo-electron microscopy of YvcC, an
RT   homodimeric ATP-binding cassette transporter from Bacillus subtilis.";
RL   J. Mol. Biol. 315:1075-1085(2002).
RN   [5]
RP   BIOPHYSICOCHEMICAL PROPERTIES, PROBABLE CATALYTIC RESIDUE, AND MUTAGENESIS
RP   OF GLU-504.
RX   PubMed=12968023; DOI=10.1074/jbc.m308268200;
RA   Orelle C., Dalmas O., Gros P., Di Pietro A., Jault J.-M.;
RT   "The conserved glutamate residue adjacent to the Walker-B motif is the
RT   catalytic base for ATP hydrolysis in the ATP-binding cassette transporter
RT   BmrA.";
RL   J. Biol. Chem. 278:47002-47008(2003).
RN   [6]
RP   SUBSTRATES, DISRUPTION PHENOTYPE, INHIBITION BY RESERPINE, AND MUTAGENESIS
RP   OF LYS-380.
RX   PubMed=15182191; DOI=10.1021/bi0362018;
RA   Steinfels E., Orelle C., Fantino J.-R., Dalmas O., Rigaud J.-L.,
RA   Denizot F., Di Pietro A., Jault J.-M.;
RT   "Characterization of YvcC (BmrA), a multidrug ABC transporter
RT   constitutively expressed in Bacillus subtilis.";
RL   Biochemistry 43:7491-7502(2004).
RN   [7]
RP   SUBUNIT.
RX   PubMed=15766260; DOI=10.1021/bi0482809;
RA   Dalmas O., Do Cao M.-A., Lugo M.R., Sharom F.J., Di Pietro A., Jault J.-M.;
RT   "Time-resolved fluorescence resonance energy transfer shows that the
RT   bacterial multidrug ABC half-transporter BmrA functions as a homodimer.";
RL   Biochemistry 44:4312-4321(2005).
RN   [8]
RP   CROSS-LINKING STUDIES, AND CATALYTIC MODEL.
RX   PubMed=16107340; DOI=10.1074/jbc.m503266200;
RA   Dalmas O., Orelle C., Foucher A.-E., Geourjon C., Crouzy S., Di Pietro A.,
RA   Jault J.-M.;
RT   "The Q-loop disengages from the first intracellular loop during the
RT   catalytic cycle of the multidrug ABC transporter BmrA.";
RL   J. Biol. Chem. 280:36857-36864(2005).
RN   [9]
RP   SUBUNIT, AND PH DEPENDENCE.
RX   PubMed=16405427; DOI=10.1042/bj20051719;
RA   Ravaud S., Do Cao M.-A., Jidenko M., Ebel C., Le Maire M., Jault J.-M.,
RA   Di Pietro A., Haser R., Aghajari N.;
RT   "The ABC transporter BmrA from Bacillus subtilis is a functional dimer when
RT   in a detergent-solubilized state.";
RL   Biochem. J. 395:345-353(2006).
RN   [10]
RP   ATP-BINDING OF MUTANTS, AND CATALYTIC MODEL.
RX   PubMed=18215075; DOI=10.1021/bi702303s;
RA   Orelle C., Gubellini F., Durand A., Marco S., Levy D., Gros P.,
RA   Di Pietro A., Jault J.-M.;
RT   "Conformational change induced by ATP binding in the multidrug ATP-binding
RT   cassette transporter BmrA.";
RL   Biochemistry 47:2404-2412(2008).
CC   -!- FUNCTION: An efflux transporter able to transport Hoechst 33342,
CC       ethidium bromide, doxorubicin and a number of other drugs in vitro into
CC       inside out vesicles. The endogenous substrate is unknown. It has been
CC       suggested that NBD dimerization induced by ATP-binding causes a large
CC       conformational change responsible for substrate translocation
CC       (PubMed:18215075). Transmembrane domains (TMD) form a pore in the inner
CC       membrane and the ATP-binding domain (NBD) is responsible for energy
CC       generation (Probable). {ECO:0000269|PubMed:18215075, ECO:0000305}.
CC   -!- ACTIVITY REGULATION: 50% inhibited by vanadate; it has been suggested
CC       that vanadate fully inhibits the dimer but not the monomer
CC       (PubMed:15766260). Activated by 15 uM reserpine then inhibited by
CC       higher concentrations. {ECO:0000269|PubMed:15766260}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Vmax=6.5 umol/min/mg enzyme for ATP {ECO:0000269|PubMed:12968023};
CC         Note=Reconstituted in proteoliposomes (PubMed:12968023).;
CC       pH dependence:
CC         Optimum pH is 8.0. {ECO:0000269|PubMed:12225846,
CC         ECO:0000269|PubMed:12968023, ECO:0000269|PubMed:16405427};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11827477,
CC       ECO:0000269|PubMed:15766260, ECO:0000269|PubMed:16405427}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- DOMAIN: In BmrA the ATP-binding domain (NBD) and the transmembrane
CC       domain (TMD) are fused. This is considered to be a half-size
CC       transporter that undergoes homodimerization to be functional.
CC   -!- DISRUPTION PHENOTYPE: Not essential. {ECO:0000269|PubMed:15182191}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z94043; CAB08051.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB15487.1; -; Genomic_DNA.
DR   PIR; D70031; D70031.
DR   RefSeq; NP_391362.1; NC_000964.3.
DR   RefSeq; WP_003243345.1; NZ_JNCM01000033.1.
DR   PDB; 6R72; X-ray; 3.95 A; A/B/C/D=1-589.
DR   PDB; 6R81; EM; 3.90 A; A/B=1-589.
DR   PDB; 7OW8; EM; 3.50 A; A/B=1-586.
DR   PDBsum; 6R72; -.
DR   PDBsum; 6R81; -.
DR   PDBsum; 7OW8; -.
DR   AlphaFoldDB; O06967; -.
DR   SMR; O06967; -.
DR   STRING; 224308.BSU34820; -.
DR   TCDB; 3.A.1.117.3; the atp-binding cassette (abc) superfamily.
DR   PaxDb; O06967; -.
DR   PRIDE; O06967; -.
DR   EnsemblBacteria; CAB15487; CAB15487; BSU_34820.
DR   GeneID; 936559; -.
DR   KEGG; bsu:BSU34820; -.
DR   PATRIC; fig|224308.179.peg.3770; -.
DR   eggNOG; COG1132; Bacteria.
DR   InParanoid; O06967; -.
DR   OMA; ERQRMTI; -.
DR   PhylomeDB; O06967; -.
DR   BioCyc; BSUB:BSU34820-MON; -.
DR   SABIO-RK; O06967; -.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0140359; F:ABC-type transporter activity; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0034040; F:ATPase-coupled lipid transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   GO; GO:0055085; P:transmembrane transport; IBA:GO_Central.
DR   Gene3D; 1.20.1560.10; -; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR039421; Type_1_exporter.
DR   PANTHER; PTHR24221; PTHR24221; 1.
DR   Pfam; PF00664; ABC_membrane; 1.
DR   Pfam; PF00005; ABC_tran; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF90123; SSF90123; 1.
DR   PROSITE; PS50929; ABC_TM1F; 1.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic resistance; ATP-binding; Cell membrane; Membrane;
KW   Nucleotide-binding; Reference proteome; Translocase; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..589
FT                   /note="Multidrug resistance ABC transporter ATP-
FT                   binding/permease protein BmrA"
FT                   /id="PRO_0000375872"
FT   TRANSMEM        29..49
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TRANSMEM        67..87
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TRANSMEM        142..162
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TRANSMEM        164..184
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TRANSMEM        249..269
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TRANSMEM        278..298
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          29..309
FT                   /note="ABC transmembrane type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          341..576
FT                   /note="ABC transporter"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   ACT_SITE        504
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305"
FT   BINDING         374..381
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000305"
FT   MUTAGEN         380
FT                   /note="K->A: Complete loss of ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:15182191"
FT   MUTAGEN         380
FT                   /note="K->R: Retains 2% ATPase activity; unable to
FT                   transport Hoechst 33342. Traps ADP in a beryllium fluoride-
FT                   dependent manner, confirming ATPase activity. Probably
FT                   unable to undergo NBD dimerization."
FT                   /evidence="ECO:0000269|PubMed:15182191"
FT   MUTAGEN         504
FT                   /note="E->A,C,D,Q,S: Complete loss of ATPase activity;
FT                   mutant proteins trap ATP in a vanadate-independent manner
FT                   whereas the wild-type protein traps ADP."
FT                   /evidence="ECO:0000269|PubMed:12968023"
FT   HELIX           12..21
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           26..49
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   TURN            50..52
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           53..63
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           66..107
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           112..117
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           120..125
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           131..139
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           141..162
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           165..209
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           210..212
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           213..218
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   TURN            219..221
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           222..247
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           250..276
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           280..292
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           294..314
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   TURN            315..319
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           320..322
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          341..343
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          345..348
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          356..360
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          368..373
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          378..380
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           381..386
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   TURN            387..389
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          394..396
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          398..404
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           405..407
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           410..414
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          417..420
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          428..430
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           431..436
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           445..454
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           458..461
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   TURN            462..468
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           474..476
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           483..494
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          498..504
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          507..509
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           511..524
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   TURN            525..527
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          528..533
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           537..539
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          544..550
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   STRAND          553..558
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           560..566
FT                   /evidence="ECO:0007829|PDB:7OW8"
FT   HELIX           571..585
FT                   /evidence="ECO:0007829|PDB:7OW8"
SQ   SEQUENCE   589 AA;  64519 MW;  8A15163B5698DA08 CRC64;
     MPTKKQKSKS KLKPFFALVR RTNPSYGKLA FALALSVVTT LVSLLIPLLT KQLVDGFSMS
     NLSGTQIGLI ALVFFVQAGL SAYATYALNY NGQKIISGLR ELLWKKLIKL PVSYFDTNAS
     GETVSRVTND TMVVKELITT HISGFITGII SVIGSLTILF IMNWKLTLLV LVVVPLAALI
     LVPIGRKMFS ISRETQDETA RFTGLLNQIL PEIRLVKASN AEDVEYGRGK MGISSLFKLG
     VREAKVQSLV GPLISLVLMA ALVAVIGYGG MQVSSGELTA GALVAFILYL FQIIMPMGQI
     TTFFTQLQKS IGATERMIEI LAEEEEDTVT GKQIENAHLP IQLDRVSFGY KPDQLILKEV
     SAVIEAGKVT AIVGPSGGGK TTLFKLLERF YSPTAGTIRL GDEPVDTYSL ESWREHIGYV
     SQESPLMSGT IRENICYGLE RDVTDAEIEK AAEMAYALNF IKELPNQFDT EVGERGIMLS
     GGQRQRIAIA RALLRNPSIL MLDEATSSLD SQSEKSVQQA LEVLMEGRTT IVIAHRLSTV
     VDADQLLFVE KGEITGRGTH HELMASHGLY RDFAEQQLKM NADLENKAG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024